Loading...
Dopamine Agonists for Pituitary Adenomas
Dopamine agonists (DA) are well established as first-line therapy for prolactinomas. These tumors express high levels of dopamine 2 receptors (D2R), leading to the strong efficacy of DA in reducing tumor size and hormonal secretion. Other pituitary tumor subtypes express D2R to varying degrees, lead...
Saved in:
| Published in: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6110840/ https://ncbi.nlm.nih.gov/pubmed/30186234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00469 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|